- Home
- THRD vs CGC Comparison
THRD vs CGC Comparison
Compare THRD & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- CGC
- Stock Information
- Founded
- THRD 2019
- CGC 2009
- Country
- THRD United States
- CGC Canada
- Employees
- THRD N/A
- CGC N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- THRD Health Care
- CGC Health Care
- Exchange
- THRD Nasdaq
- CGC Nasdaq
- Market Cap
- THRD 164.2M
- CGC 174.9M
- IPO Year
- THRD 2022
- CGC N/A
- Fundamental
- Price
- THRD $5.14
- CGC $1.41
- Analyst Decision
- THRD Hold
- CGC Sell
- Analyst Count
- THRD 3
- CGC 2
- Target Price
- THRD $5.00
- CGC $2.00
- AVG Volume (30 Days)
- THRD 1.2M
- CGC 6.9M
- Earning Date
- THRD 05-14-2025
- CGC 05-29-2025
- Dividend Yield
- THRD N/A
- CGC N/A
- EPS Growth
- THRD N/A
- CGC N/A
- EPS
- THRD N/A
- CGC N/A
- Revenue
- THRD N/A
- CGC $192,343,833.00
- Revenue This Year
- THRD N/A
- CGC N/A
- Revenue Next Year
- THRD N/A
- CGC $2.50
- P/E Ratio
- THRD N/A
- CGC N/A
- Revenue Growth
- THRD N/A
- CGC N/A
- 52 Week Low
- THRD $3.18
- CGC $0.77
- 52 Week High
- THRD $16.94
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- THRD 79.10
- CGC 61.94
- Support Level
- THRD $5.08
- CGC $1.04
- Resistance Level
- THRD $5.20
- CGC $1.30
- Average True Range (ATR)
- THRD 0.11
- CGC 0.15
- MACD
- THRD 0.13
- CGC 0.07
- Stochastic Oscillator
- THRD 96.84
- CGC 73.14
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.